J. Safra Sarasin Holding AG Raises Stock Holdings in Stryker Corporation $SYK

Key Points

• J. Safra Sarasin Holding AG increased its holdings in Stryker Corporation by 58.4% in Q2, owning 3,956 shares valued at approximately $1.57 million.
• Analysts generally hold a Moderate Buy rating for Stryker, with a consensus price target of $430.33 and a mix of buy and hold ratings from various firms.
• Stryker announced a quarterly dividend of $0.84 per share, set to be paid on October 31st, reflecting a 0.9% dividend yield.

J. Safra Sarasin Holding AG increased its position in Stryker Corporation (NYSE:SYK - Free Report) by 58.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,956 shares of the medical technology company's stock after acquiring an additional 1,459 shares during the period. J. Safra Sarasin Holding AG's holdings in Stryker were worth $1,565,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SYK. Brighton Jones LLC grew its position in shares of Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock valued at $1,643,000 after acquiring an additional 609 shares during the period. Portside Wealth Group LLC grew its position in shares of Stryker by 16.0% during the 1st quarter. Portside Wealth Group LLC now owns 682 shares of the medical technology company's stock valued at $246,000 after acquiring an additional 94 shares during the period. Retirement Planning Group LLC acquired a new stake in shares of Stryker during the 1st quarter valued at about $212,000. Breakwater Capital Group grew its position in shares of Stryker by 31.5% during the 1st quarter. Breakwater Capital Group now owns 2,123 shares of the medical technology company's stock valued at $790,000 after acquiring an additional 508 shares during the period. Finally, Vest Financial LLC acquired a new stake in shares of Stryker during the 1st quarter valued at about $203,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Rothschild Redb upgraded Stryker to a "hold" rating in a research report on Thursday, September 18th. Truist Financial set a $415.00 price objective on Stryker and gave the stock a "hold" rating in a report on Monday, August 4th. Redburn Partners set a $420.00 price objective on Stryker in a report on Thursday, September 18th. Weiss Ratings reiterated a "buy (b-)" rating on shares of Stryker in a report on Saturday, September 27th. Finally, BTIG Research reiterated a "buy" rating on shares of Stryker in a report on Monday, July 14th. Fifteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, Stryker presently has an average rating of "Moderate Buy" and a consensus price target of $430.33.

Stryker Trading Up 1.1%

SYK opened at $370.59 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. The company's 50 day simple moving average is $382.81 and its two-hundred day simple moving average is $378.92. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $406.19. The firm has a market capitalization of $141.68 billion, a price-to-earnings ratio of 49.08, a price-to-earnings-growth ratio of 2.64 and a beta of 0.94.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, topping analysts' consensus estimates of $3.07 by $0.06. The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business's revenue was up 11.1% on a year-over-year basis. During the same period last year, the company posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Analysts expect that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker's payout ratio is presently 44.50%.

Insider Activity at Stryker

In other news, insider Viju Menon sold 500 shares of Stryker stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider owned 12,511 shares of the company's stock, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the sale, the director directly owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. The trade was a 5.84% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by insiders.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.